NIH Launches New Childhood Cancer Genomics Program
Pediatric and young adult patients treated at facilities affiliated with the NCI-sponsored Children's Oncology Group gain new, broad access to tumor molecular profiling.
Thermo Fisher Scientific, Agios Pharmaceuticals to Codevelop Glioma Companion Diagnostic
Thermo will develop a test using its Oncomine Precision Assay to identify IDH1- and IDH2-positive low-grade glioma patients for treatment with Agios' vorasidenib.
Memorial Sloan Kettering Using Cerebral Spinal Fluid Liquid Biopsy, Sequencing to Track Glioma Evolution
The researchers believe using cerebral spinal fluid will enable them to identify brain tumors with a higher sensitivity than with blood samples.
The researchers aim to offer the half-hour diagnostic assay for use during neurosurgery to help clinicians pursue the best treatment for patients with gliomas.
The researchers said that their deep-learning interpreter of outcomes for patients with gliomas could be more accurate and objective than pathologists.